← REGULATORY CHANGES
FEDERAL REGISTER · RULEMay 9, 2025IN FORCE

Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Measure Non-Microbial Analytes To Aid in the Detection and Identification of Localized Human Infections

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVEMay 9, 2025
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGDevice
Document type
Rule
Agency
Health and Human Services Department
Published
May 9, 2025
Effective
May 9, 2025
Document number
2025-08144
CFR references
21 CFR 866
Docket
FDA-2025-N-0781
ABSTRACT

The Food and Drug Administration (FDA, the Agency, or we) is classifying the device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections' classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Abstract as published in the Federal Register.